Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 2016-07-31 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 2017-03-31 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2021-07-14 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -1.65% | +39.85% | +95.40% | 68.87B | |
| +1.31% | +0.55% | +49.48% | +90.80% | 65.29B | |
| +0.04% | +4.36% | -11.72% | +459.54% | 27.65B | |
| +2.97% | -0.10% | +41.86% | +14.84% | 25.77B | |
| -0.90% | -7.65% | +2.45% | -15.50% | 26.08B | |
| +1.01% | +1.76% | +32.99% | -17.16% | 20.14B | |
| +3.45% | -14.83% | +225.22% | +389.50% | 17.03B | |
| +0.77% | -4.55% | -0.36% | +549.41% | 15.03B | |
| +1.03% | +7.00% | +59.98% | +160.03% | 14.5B | |
| Average | +1.12% | -1.22% | +48.86% | +191.87% | 31.15B | |
| Weighted average by Cap. | +0.98% | -0.54% | +43.36% | +149.98% |
